Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03690115
Title Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (Allo-SCT) in FLT3-ITD AML Patients (PONALLO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Versailles Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Angers Angers France Details
CHu Brest Brest France Details
CHU Caen Caen France Details
CHU Clermont Ferrand Clermont Ferrand France Details
CHU Grenoble Grenoble France Details
CHU Lille Lille France Details
CHU Limoges Limoges France Details
Chevallier Nantes France Details
Hopital St Antoine Paris France Details
Hopital St Louis Paris France Details
CHu Lyon Pierre-Bénite France Details
CHU Poitiers Poitiers France Details
CRLC Toulouse Toulouse France Details
CHU Nancy Vandœuvre-lès-Nancy France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field